Bret Kenwell is a freelance writer for TheStreet. He studied finance at Central Michigan University and seeks out companies that have the ability to generate above-average growth for many years. Ultimately, the goal is for those companies to become dividend paying titans, cementing their spot in one's portfolio with an incredibly low cost basis. Those picks and Bret's blog can be found at FutureBlueChips.com
Recent Articles By The Author
Cisco Does Something That Makes Another Tech Stock a Worthy Buy
Rising DRAM prices are hurting Cisco -- but that's a good thing for Micron and Lam Research.
Applied Materials Stock to Rally More Than 40%: Analysts
Three analysts raised their price target on AMAT stock, the lowest of which implies about 40% upside.
Alibaba Just Delivered on Promise to Become an Online Colossus, Jim Cramer Says
Alibaba crushed earnings and revenue expectations.
Regeneron, BioMarin, AbbVie Could Explode 20% or More -- Analyst
Evercore ISI analyst Josh Schimmer is bullish on biotech.
Jim Cramer -- Here's How to Play Alibaba's Usually Volatile Earnings Report
Alibaba is up 80% on the year.